Dr. Matthew Boente MD, an obstetrician, gynecologist, and gynecologic oncologist, took part in the study of using bevacizumab in treating ovarian cancer. In 2018, the Food and Drug Administration (FDA) approved the use of bevacizumab (Avastin) manufactured by Genentech, Inc. for the treatment of epithelial ovarian, fallopian tube or primary peritoneal cancer. The medication isContinue reading “How can Avastin aid in treating ovarian cancer?”
-
Subscribe
Subscribed
Already have a WordPress.com account? Log in now.
Dr Matthew Boente MD 